LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma Via Sponging MiR-424-5p
Overview
Authors
Affiliations
Objective: Hepatocellular carcinoma (HCC) results in high mortality and metastasis. In this study, the effects of long non-coding RNA (lncRNA) CDKN2B-AS1 on the progression of HCC were investigated.
Materials And Methods: LncRNA CDKN2B-AS1 expression of HCC cancer and adjacent tissues, and HCC cells were detected. Subsequently, CDKN2B-AS1 was overexpressed and silenced in HCC cells to observe the effects of CDKN2B-AS1 on the cell viability, migration, invasion, and epithelial-mesenchymal transition (EMT) of HCC cells by performing cell counting kit-8 (CCK-8), wound-healing, Transwell, and Western blot. The target gene of CDKN2B-AS1 was predicted and verified to be miR-424-5p, whose expression in HCC cells with up- or down-regulation of CDKN2B-AS1 expression was determined. Moreover, the effects of miR-424-5p on cell viability, migration, and invasion and EMT of HCC cells were investigated with miR-424-5p up-regulation or down-regulation, together with overexpression or silencing of CDKN2B-AS1.
Results: CDKN2B-AS1 expression was increased in HCC tissues and cells. Silencing of CDKN2B-AS1 suppressed cell viability, migration, invasion, and EMT, while overexpression of CDKN2B-AS1 produced the opposite results. Furthermore, CDKN2B-AS1 was predicted and verified to target miR-424-5p and was confirmed to negatively modulate miR-424-5p expression. Moreover, overexpression of miR-424-5p partially suppressed the previously high cell viability, migration, and invasion, and activated EMT resulted from up-regulation of CDKN2B-AS1, while silencing of miR-424-5p elevated the cellular processes inhibited by silencing the expression of CDKN2B-AS1.
Conclusion: The present study revealed that high-expressed CDKN2B-AS1 may associate with the progression of HCC by affecting the cell viability, migration, invasion, and EMT of HCC cells by negatively regulating miR-424-5p.
Tao Z, Yuan Y, Wang G World J Gastrointest Oncol. 2023; 15(11):1974-1987.
PMID: 38077646 PMC: 10701227. DOI: 10.4251/wjgo.v15.i11.1974.
The Long Non-Coding RNA ANRIL in Cancers.
Sanchez A, Lhuillier J, Grosjean G, Ayadi L, Maenner S Cancers (Basel). 2023; 15(16).
PMID: 37627188 PMC: 10453084. DOI: 10.3390/cancers15164160.
Role of miR-424 in the carcinogenesis.
Ghafouri-Fard S, Askari A, Hussen B, Taheri M, Dilmaghani N Clin Transl Oncol. 2023; 26(1):16-38.
PMID: 37178445 PMC: 10761534. DOI: 10.1007/s12094-023-03209-2.
LncRNA SNHG1 promotes nasopharyngeal carcinoma development via targeting miR-424-5p.
Zhou Z, Chen Y Histol Histopathol. 2023; 38(8):953-963.
PMID: 36727428 DOI: 10.14670/HH-18-589.
Wu Q, He Y, Liu X, Luo F, Jiang Y, Xiang M Regen Ther. 2022; 22:19-29.
PMID: 36582605 PMC: 9772501. DOI: 10.1016/j.reth.2022.11.005.